European Journal of Nuclear Medicine and Molecular Imaging This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Diagnostic performance of molecular imaging methods in predicting the progression from mild cognitive impairment to dementia: an updated systematic review
ConclusionMolecular imaging has a moderate-to-good accuracy in predicting the progression of MCI to Alzheimer ’s dementia. Longitudinal studies are sparse in non-AD conditions, requiring additional efforts in these settings. (Source: European Journal of Nuclear Medicine and Molecular Imaging)
Source: European Journal of Nuclear Medicine and Molecular Imaging - February 15, 2024 Category: Nuclear Medicine Source Type: research

Prognostic value of baseline and interim [18F]FDG PET metabolic parameters in pediatric Hodgkin ’s lymphoma
ConclusionBaseline and interim [18F]FDG PET parameters can serve as significant prognostic indicators for EFS and treatment response in pediatric HL. These quantitative measures could enhance individualized, risk-adapted treatment strategies for children and adolescents with HL. (Source: European Journal of Nuclear Medicine and Molecular Imaging)
Source: European Journal of Nuclear Medicine and Molecular Imaging - February 14, 2024 Category: Nuclear Medicine Source Type: research

Long-axial-field of view in prostate cancer next generation imaging: the launch pad of theragnostic
(Source: European Journal of Nuclear Medicine and Molecular Imaging)
Source: European Journal of Nuclear Medicine and Molecular Imaging - February 14, 2024 Category: Nuclear Medicine Source Type: research

90Y post-radioembolization clinical assessment with whole-body Biograph Vision Quadra PET/CT: image quality, tumor, liver and lung dosimetry
ConclusionIn this study we evaluated, in terms of image quality and dosimetry, whole-body PET clinical images of patients after having been treated with90Y microspheres radioembolization for liver cancer. Compared to the 20-min standard scan, the simulated 5-min reconstructed images provided equal image peak SNR and noise behavior, while performing also similarly for post-treatment dosimetry of tumor, whole liver and lung absorbed doses. (Source: European Journal of Nuclear Medicine and Molecular Imaging)
Source: European Journal of Nuclear Medicine and Molecular Imaging - February 13, 2024 Category: Nuclear Medicine Source Type: research

Incorporating the [68Ga]Ga-PSMA PET/CT PRIMARY score into the selection criteria for prostate cancer patients eligible for active surveillance
(Source: European Journal of Nuclear Medicine and Molecular Imaging)
Source: European Journal of Nuclear Medicine and Molecular Imaging - February 12, 2024 Category: Nuclear Medicine Source Type: research

Epithelioid hemangioma, a benign vascular lesion mimicking malignancy in [18F]FDG PET/CT
(Source: European Journal of Nuclear Medicine and Molecular Imaging)
Source: European Journal of Nuclear Medicine and Molecular Imaging - February 12, 2024 Category: Nuclear Medicine Source Type: research

A patient journey audit tool (PJAT) to assess quality indicators in a nuclear medicine service
ConclusionThis PJAT can be applied in nuclear medicine departments to enhance quality programmes and patient care. Austin Health has collaborated with the IAEA to formulate the IAEA PJAT, which is now available globally for nuclear medicine departments to survey patient journeys. (Source: European Journal of Nuclear Medicine and Molecular Imaging)
Source: European Journal of Nuclear Medicine and Molecular Imaging - February 10, 2024 Category: Nuclear Medicine Source Type: research

Gallium-68 labeled somatostatin receptor antagonist PET/CT in over 500 patients with neuroendocrine neoplasms: experience from a single center in China
ConclusionGallium-68 labeled SSTR antagonists could serve as alternatives to SSTR agonists for imaging of NENs. Among various antagonists, [68Ga]Ga-NODAGA-LM3 seems to have the best imaging profile. (Source: European Journal of Nuclear Medicine and Molecular Imaging)
Source: European Journal of Nuclear Medicine and Molecular Imaging - February 10, 2024 Category: Nuclear Medicine Source Type: research